A study to find out whether the medication pasireotide is absorbed and processed the same way when given under the skin using either a reusable pen or a syringe in healthy subjects
This study is about a medicine called pasireotide, which is being investigated for a condition where blood sugar levels drop too low after weight loss surgery. The main goal of this study is to check how your body takes in and uses this medicine. We're especially interested in comparing two different ways of giving the medicine: either with a reusable injection pen or with a standard syringe (needle and plunger). This is a very early stage study, often called a Phase 1 study, and it involves healthy volunteers. By understanding how the body processes the medicine when given in these different ways, we can help make sure it works as expected for future patients. This study does not involve actual patients with the low blood sugar condition, but focuses on how the medicine behaves in the body of healthy people.
At a glance
What is this study about?
Imagine you need a specific medicine, and there are a couple of different ways to get it into your body – maybe one way is easier or more comfortable than another. This study is similar: we're looking at a medicine called pasireotide that can be given by an injection just under the skin. We want to see if your body deals with this medicine in exactly the same way, whether it's given with a special reusable pen that has the medicine inside, or with a more traditional single-use syringe and needle.
This kind of study is called a 'Human Pharmacology' or 'Phase I' study. This means it's one of the very first times the medicine is being tested in people. Scientists want to understand basic things like how much of the medicine gets into your bloodstream, how long it stays there, and how your body breaks it down. By doing this in healthy volunteers, we can get a clear picture of how the medicine works without other health conditions making it complicated.
The information from this study is really important. Even though it's not directly testing if the medicine treats a specific illness right now, understanding how it behaves in the body is a key step. It helps doctors and researchers choose the best ways to give the medicine in the future and ensures that if it becomes a treatment for conditions like very low blood sugar after weight loss surgery, it will be given effectively and safely.
Key takeaways
- Study examines how medicine pasireotide is absorbed in the body.
- Compares two injection methods: reusable pen vs. standard syringe.
- Participation is for healthy adults, aged 18 and over.
- Aims to gather basic information about the medicine's behaviour in the body.
- Early stage (Phase I) research, not a treatment trial.
- You can withdraw from the study at any point.
Who may be eligible?
This study is looking for healthy adults to take part. To be considered, you need to be at least 18 years old. There is no upper age limit, meaning older adults can also participate as long as they are generally healthy.
Both men and women are welcome to join this study. The main idea is that participants should be in good general health, as confirmed by a medical check-up, because the study wants to understand how the medicine works in a typical, healthy body.
Specific health conditions or current medications might mean you can't take part, as these could affect how the study medicine works or make your participation unsafe. The study team will discuss all of these details with you thoroughly.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you at least 18 years old?
- Are you generally healthy?
- Are you able to attend several clinic visits?
- Are you comfortable receiving injections under your skin?
- Do you understand this is for research and not for treating an illness?
What does participation involve?
If you decide to take part, you'll be given the study medicine, pasireotide, as an injection under the skin. You'll get this medicine in two different ways during the study: sometimes using a reusable pen, and at other times using a standard syringe and needle. This allows the researchers to compare how your body handles the medicine from each method.
You will need to attend several visits to a clinic over a period of time. These visits will involve various health checks, such as blood tests, to measure how the medicine is absorbed and processed by your body. The study team will provide all the necessary information about these visits, including what to expect at each one and how long they might last. The total duration of your participation in the study, including all visits and follow-up, will be explained to you in detail.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is pasireotide?
Pasireotide is a medicine being studied. This particular study is looking at how your body handles it when given in different ways.
Why are you using healthy people?
By using healthy volunteers, researchers can get a clear idea of how the medicine works in the body without other health conditions making it complicated.
What's the difference between a 'pen' and a 'syringe' injection?
A pen is a special device with the medicine inside, often designed to be easy to use. A syringe is the more traditional needle and plunger method. We want to see if your body uses the medicine the same way from both.
Will this study cure any illness?
No, this study is not designed to cure an illness. It's an early-stage study to understand how a medicine works, which can help in developing future treatments.
Do I get paid for taking part?
This is a common question. Any compensation for your time and inconvenience will be fully explained to you by the study team before you agree to take part.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.